Omeros Corp. (OMER)
11.54
+0.05
(+0.44%)
USD |
NASDAQ |
Mar 06, 16:00
11.54
0.00 (0.00%)
After-Hours: 20:00
Omeros SG&A Expense (TTM) : 44.20M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Edgewise Therapeutics, Inc. | 40.02M |
| Boston Scientific Corp. | 6.888B |
| Gilead Sciences, Inc. | 8.398B |
| REGENXBIO, Inc. | 60.48M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |